ICIF, Portland PE fund invest in German radiopharma business

ITM Isotope Technologies Munich, a German radiopharmaceutical biotechnology company, has secured a €33 million ($36 million) investment.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this